Puzo Michael J grew its position in shares of CVS Health Corp (NYSE:CVS) by 7.6% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 73,353 shares of the pharmacy operator’s stock after buying an additional 5,193 shares during the quarter. CVS Health accounts for 2.2% of Puzo Michael J’s investment portfolio, making the stock its 19th largest holding. Puzo Michael J’s holdings in CVS Health were worth $5,318,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently made changes to their positions in CVS. Beach Investment Management LLC. acquired a new position in shares of CVS Health during the 2nd quarter worth $2,224,000. LSV Asset Management grew its stake in shares of CVS Health by 6.6% during the 2nd quarter. LSV Asset Management now owns 4,882,891 shares of the pharmacy operator’s stock worth $392,877,000 after purchasing an additional 302,975 shares during the period. Dearborn Partners LLC grew its stake in shares of CVS Health by 2.3% during the 2nd quarter. Dearborn Partners LLC now owns 229,770 shares of the pharmacy operator’s stock worth $18,487,000 after purchasing an additional 5,253 shares during the period. Sheaff Brock Investment Advisors LLC grew its stake in shares of CVS Health by 5.5% during the 2nd quarter. Sheaff Brock Investment Advisors LLC now owns 80,423 shares of the pharmacy operator’s stock worth $6,471,000 after purchasing an additional 4,196 shares during the period. Finally, IFM Investors Pty Ltd grew its stake in shares of CVS Health by 106.0% during the 2nd quarter. IFM Investors Pty Ltd now owns 28,129 shares of the pharmacy operator’s stock worth $2,263,000 after purchasing an additional 14,476 shares during the period. Institutional investors own 83.96% of the company’s stock.
A number of equities research analysts recently commented on the stock. ValuEngine cut shares of CVS Health from a “buy” rating to a “hold” rating in a research note on Sunday, December 31st. Vetr cut shares of CVS Health from a “buy” rating to a “hold” rating and set a $77.11 price objective on the stock. in a research note on Thursday, January 4th. SunTrust Banks increased their price objective on shares of CVS Health to $90.00 and gave the company a “buy” rating in a research note on Friday, January 5th. Morgan Stanley raised shares of CVS Health from an “equal weight” rating to an “overweight” rating and set a $88.00 price objective on the stock in a research note on Friday, January 5th. Finally, Robert W. Baird set a $77.00 price objective on shares of CVS Health and gave the company a “hold” rating in a research note on Monday, December 4th. Two analysts have rated the stock with a sell rating, seven have given a hold rating, twelve have given a buy rating and two have given a strong buy rating to the company. The stock presently has an average rating of “Buy” and an average target price of $87.03.
In other CVS Health news, EVP Lisa Bisaccia sold 29,445 shares of the company’s stock in a transaction dated Thursday, December 21st. The shares were sold at an average price of $75.00, for a total value of $2,208,375.00. Following the transaction, the executive vice president now directly owns 15,556 shares in the company, valued at approximately $1,166,700. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, EVP Helena Foulkes sold 19,965 shares of the company’s stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $71.04, for a total transaction of $1,418,313.60. Following the completion of the transaction, the executive vice president now owns 65,072 shares in the company, valued at $4,622,714.88. The disclosure for this sale can be found here. 0.61% of the stock is currently owned by corporate insiders.
CVS Health Corp (NYSE:CVS) opened at $63.63 on Tuesday. The stock has a market cap of $66,604.02, a PE ratio of 9.83, a price-to-earnings-growth ratio of 1.09 and a beta of 1.03. The company has a quick ratio of 0.52, a current ratio of 1.02 and a debt-to-equity ratio of 0.59. CVS Health Corp has a 1-year low of $63.31 and a 1-year high of $84.00.
CVS Health (NYSE:CVS) last released its earnings results on Thursday, February 8th. The pharmacy operator reported $1.92 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.88 by $0.04. The company had revenue of $48.39 billion for the quarter, compared to analyst estimates of $47.54 billion. CVS Health had a net margin of 3.58% and a return on equity of 17.21%. The firm’s quarterly revenue was up 5.3% on a year-over-year basis. During the same period in the prior year, the firm earned $1.71 EPS. equities research analysts predict that CVS Health Corp will post 6.37 earnings per share for the current year.
The company also recently announced a quarterly dividend, which will be paid on Thursday, May 3rd. Shareholders of record on Monday, April 23rd will be issued a $0.50 dividend. The ex-dividend date of this dividend is Friday, April 20th. This represents a $2.00 dividend on an annualized basis and a yield of 3.14%. CVS Health’s dividend payout ratio (DPR) is 30.91%.
COPYRIGHT VIOLATION NOTICE: “Puzo Michael J Has $5.32 Million Holdings in CVS Health Corp (CVS)” was originally published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this report on another website, it was stolen and republished in violation of US and international copyright laws. The legal version of this report can be viewed at https://ledgergazette.com/2018/03/20/puzo-michael-j-has-5-32-million-holdings-in-cvs-health-corp-cvs.html.
CVS Health Company Profile
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.